Time-dependent reduction in Aβ levels after intracranial LPS administration in APP transgenic mice
- 30 November 2004
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 190 (1) , 245-253
- https://doi.org/10.1016/j.expneurol.2004.07.007
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administrationNeurobiology of Disease, 2003
- Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid β peptide in APPswe transgenic miceNeurobiology of Disease, 2003
- Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's diseaseJournal of Neuroimmunology, 2003
- Microglia as neuroprotective, immunocompetent cells of the CNSGlia, 2002
- Time Course of the Development of Alzheimer-like Pathology in the Doubly Transgenic PS1+APP MouseExperimental Neurology, 2002
- Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic miceNeurobiology of Aging, 2001
- Lymphocyte Fc receptors: Expression, regulation and functionMolecular Immunology, 1990
- Regulation of Fcγ R II expression and function by B lymphocyte activatorsMolecular Immunology, 1990
- Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damageNeuron, 1989
- FcγRII expression in resting and activated B lymphocytesEuropean Journal of Immunology, 1989